Origimm Biotechnology

ProVaDis: Protection-based Vaccine Discovery

ORIGIMM PRESENTS AT THE BIOTRINITY CONFERENCE, MAY 2015, LONDON

BioTrinity is Europe’s Leading BioPartnering and Investment Conference. Origimm also took part in the program organized by the Austrian Economy Chamber in London, “Advantage Austria”, which included review of partnering opportunities available to Austrian companies in the UK and a visit to the European Medicines Agency (EMA).